- Shareholders IMCD N.V. adopt all resolutions at AGM
- IMCD reports EBITA of EUR 127 million in the first three months of 2024
- IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
- IMCD publishes convocation for its upcoming Annual General Meeting
- IMCD Benelux expands its Beauty & Personal Care presence with the acquisition of Gova Ingredients
- IMCD further expands its food and nutrition footprint in Latin America with the acquisition of Bretano
- IMCD announces dividend proposal and Supervisory Board nominations for reappointment
- IMCD reports EBITA of EUR 515 million in 2023
- IMCD Australia and New Zealand strengthen its coatings and construction business with the acquisition of ResChem
- IMCD completes acquisition of remaining 30% of Signet Excipients Private Limited
More ▼
Key statistics
On Thursday, IMCD NV (IMCD:AEX) closed at 142.65, -15.62% below its 52-week high of 169.05, set on Mar 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 145.40 |
---|---|
High | 145.45 |
Low | 142.65 |
Bid | 142.40 |
Offer | 144.90 |
Previous close | 142.65 |
Average volume | 88.39k |
---|---|
Shares outstanding | 56.99m |
Free float | 55.99m |
P/E (TTM) | 28.69 |
Market cap | 8.39bn EUR |
EPS (TTM) | 5.13 EUR |
Annual div (ADY) | 2.24 EUR |
---|---|
Annual div yield (ADY) | 1.52% |
Div ex-date | May 16 2024 |
Div pay-date | May 21 2024 |
Data delayed at least 15 minutes, as of May 16 2024 16:35 BST.
More ▼